Fund HoldingsEuclidean Capital LLC

Total Portfolio Value
$888.54M
Total Bought
$415.04M
Total Sold
$644.6K
Net Transaction
+$414.40M
Filing Period:
Securities
SharesValue ($K)
Q3 2023
Q4 2023
Change
Q3 2023
Q4 2023
Weight (%)
Change
SPDR S&P 500 ETF TR(SPY)246,250917,141+670,891105,267435,92649.06%+330,659
SPDR GOLD TR(GLD)1,062,5001,390,000+327,500182,166265,72629.91%+83,561
ISHARES TR
MSCI INDIA ETF
2,425,1442,425,1440107,240118,37113.32%+11,131
RAPT THERAPEUTICS INC657,899657,899010,93416,3491.84%+5,415
ORIC PHARMACEUTICALS INC(ORIC)989,410989,41005,9869,1031.02%+3,117
FOGHORN THERAPEUTICS INC1,573,7611,573,76107,86910,1511.14%+2,282
ALECTOR INC1,307,8581,307,85808,47510,4371.17%+1,962
SURROZEN INC087,696+87,69608240.09%+824
TENAYA THERAPEUTICS INC1,015,7051,015,70502,5903,2910.37%+701
SURROZEN INC170,833170,8330730.00%-4
NGM BIOPHARMACEUTICALS INC992,168992,16801,0628520.10%-209
SURROZEN INC1,315,4630-1,315,4636450-645
23ANDME HOLDING CO10,243,12210,243,122010,0159,3571.05%-658
PMV PHARMACEUTICALS INC2,627,6432,627,643016,1348,1460.92%-7,988
Page 1 of 1